Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping "CONSCIOUS-2"

Completed

Phase 3 Results N/A

References

Related Links

Sources for Trial Information